sulforaphane has been researched along with Leucocythaemia in 7 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) is an isothiocyanate, inducing cytotoxic effects in various human cancer cells, including leukemia cells through cell cycle arrest and apoptosis." | 7.83 | Sulforaphane promotes immune responses in a WEHI‑3‑induced leukemia mouse model through enhanced phagocytosis of macrophages and natural killer cell activities in vivo. ( Chen, YL; Chung, JG; Hsueh, SC; Lee, CH; Liao, NC; Lu, HF; Shih, YL; Wu, LY, 2016) |
| "Tanshinone IIA (Tan IIA) is a diterpene quinone extracted from the root of Salvia miltiorrhiza, a Chinese traditional herb." | 5.38 | Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling. ( Chen, S; Huang, L; Li, J; Liu, C; Meng, F; Wang, L; Wu, F; Xiao, B; Xu, Y; Yang, M; Ye, J, 2012) |
| "Sulforaphane (SFN) has been indicated for the prevention and suppression of tumorigenesis in solid tumors." | 5.38 | Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function. ( Kuo, CC; Lee, CM; Lin, LC; Wang, LS; Wu, AT; Wu, CH; Yang, WC; Yeh, CT; Yen, GC, 2012) |
| "Sulforaphane (SFN) is an isothiocyanate, inducing cytotoxic effects in various human cancer cells, including leukemia cells through cell cycle arrest and apoptosis." | 3.83 | Sulforaphane promotes immune responses in a WEHI‑3‑induced leukemia mouse model through enhanced phagocytosis of macrophages and natural killer cell activities in vivo. ( Chen, YL; Chung, JG; Hsueh, SC; Lee, CH; Liao, NC; Lu, HF; Shih, YL; Wu, LY, 2016) |
| "Although clearly effective in acute promyelocytic leukemia (APL), arsenic trioxide (ATO) demonstrates little clinical benefit as a single agent in the treatment of non-APL hematological malignancies." | 3.76 | Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism. ( Bowling, B; Doudican, NA; Orlow, SJ, 2010) |
| "Tanshinone IIA (Tan IIA) is a diterpene quinone extracted from the root of Salvia miltiorrhiza, a Chinese traditional herb." | 1.38 | Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling. ( Chen, S; Huang, L; Li, J; Liu, C; Meng, F; Wang, L; Wu, F; Xiao, B; Xu, Y; Yang, M; Ye, J, 2012) |
| "Sulforaphane (SFN) has been indicated for the prevention and suppression of tumorigenesis in solid tumors." | 1.38 | Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function. ( Kuo, CC; Lee, CM; Lin, LC; Wang, LS; Wu, AT; Wu, CH; Yang, WC; Yeh, CT; Yen, GC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suppipat, K | 1 |
| Lacorazza, HD | 1 |
| Philbrook, NA | 1 |
| Winn, LM | 1 |
| Shih, YL | 1 |
| Wu, LY | 1 |
| Lee, CH | 1 |
| Chen, YL | 1 |
| Hsueh, SC | 1 |
| Lu, HF | 1 |
| Liao, NC | 1 |
| Chung, JG | 1 |
| Doudican, NA | 1 |
| Bowling, B | 1 |
| Orlow, SJ | 1 |
| Sharma, R | 1 |
| Ellis, B | 1 |
| Sharma, A | 1 |
| Liu, C | 1 |
| Li, J | 1 |
| Wang, L | 1 |
| Wu, F | 1 |
| Huang, L | 1 |
| Xu, Y | 1 |
| Ye, J | 1 |
| Xiao, B | 1 |
| Meng, F | 1 |
| Chen, S | 1 |
| Yang, M | 1 |
| Lin, LC | 1 |
| Yeh, CT | 1 |
| Kuo, CC | 1 |
| Lee, CM | 1 |
| Yen, GC | 1 |
| Wang, LS | 1 |
| Wu, CH | 1 |
| Yang, WC | 1 |
| Wu, AT | 1 |
1 review available for sulforaphane and Leucocythaemia
| Article | Year |
|---|---|
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Topics: Animals; Antineoplastic Agents; Food; Humans; Isothiocyanates; Leukemia; Sulfoxides | 2014 |
6 other studies available for sulforaphane and Leucocythaemia
| Article | Year |
|---|---|
Benzoquinone toxicity is not prevented by sulforaphane in CD-1 mouse fetal liver cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Benzoquinones; Catalase; Cell Line; Deoxyguanosi | 2016 |
Sulforaphane promotes immune responses in a WEHI‑3‑induced leukemia mouse model through enhanced phagocytosis of macrophages and natural killer cell activities in vivo.
Topics: Animals; Cell Line, Tumor; Humans; Isothiocyanates; Killer Cells, Natural; Leukemia; Lymphocyte Acti | 2016 |
Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Death; Drug Syner | 2010 |
Role of alpha class glutathione transferases (GSTs) in chemoprevention: GSTA1 and A4 overexpressing human leukemia (HL60) cells resist sulforaphane and curcumin induced toxicity.
Topics: Blotting, Western; Curcumin; Glutathione Transferase; HL-60 Cells; Humans; Isothiocyanates; Leukemia | 2011 |
Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Chemokine CCL2; Dose-Resp | 2012 |
Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function.
Topics: ADP-ribosyl Cyclase 1; Anticarcinogenic Agents; Antigens, CD34; Antineoplastic Agents; Apoptosis; Be | 2012 |